Dear Editor, Radiation fibrosis, primary and metastatic lung cancer, and metastatic breast cancer account for almost threefourths of the causes of atraumatic brachial plexopathy [1] . Brachial plexopathy-associated breast cancer can occur by radiation injury or metastatic spread of the tumor [2] . Breast cancer is the most likely to metastasize because major lymphatic drainage routes for the breast course through the apex of the axilla [1] . The diagnosis of recurrent breast carcinoma with brachial plexus involvement is often delayed, and misinterpretation with a radiation-or chemotherapy-induced brachial plexopathy is common. Since electrophysiological evaluation, magnetic resonance imaging (MRI), and ultrasound (US) are cardinal investigations to detect a metastatic involvement of the brachial plexus, reporting this case, we aim at underlying the importance of an early recognition of a treatable brachial plexopathy.
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A 58-year-old woman was hospitalized for a 6-month history of progressive motor weakness in the upper left limb. Twelve years before, she was diagnosed with an invasive ductal carcinoma at the inner upper quadrant of the left breast, treated with neoadjuvant chemotherapy, breastconserving surgery (ypT1c; y pN3a; G3; negative hormone receptors; Herceptest: 3+), and subsequent adjuvant chemotherapy (adriamycin and paclitaxel) and radiotherapy.
Six years later, chemotherapic treatment with trastuzumab and vinorelbine was started for left axillary supra-and infraclavear recurrence; complete remission was obtained, but the patient developed cardiac toxicity, so a second-line therapy with capecitabine was preferred. After 4 years, a total-body computed tomography (CT scan) revealed lung recurrence; therapeutic response to the association of trastuzumab and vinorelbine was significant, even if the latter had to be stopped for liver toxicity. One month later, the patient developed progressive motor weakness in the upper left limb, in absence of pain. Clinical examination revealed marked muscular weakness and atrophy of deltoid and moderate weakness of biceps, triceps, and extensors of forearm and fingers, as well as absence of biceps and triceps tendon reflex. Electrophysiological findings were strongly suggestive of a left brachial plexus damage with involvement of the lateral and posterior cords (Table 1) ; stimulation from Erb's point of left musculocutaneous motor nerve, left radial motor nerve (registered at brachial triceps), and left axillary motor nerve showed that compound muscle action potential (CMAP) was absent (musculocutaneous, radial) or markedly decreased in amplitude with prolonged latency (axillary), and left radial sensory nerve was unexcitable, while left suprascapular, median (registered at abductor brevis pollicis), and ulnar nerves did not show abnormalities in motor and sensory conduction; needle electromyography revealed marked abundant fibrillation potentials and positive sharp waves in left deltoid, biceps, triceps, brachioradialis, extensor carpi radialis, and extensor digitorum communis muscles, while left supraspinatus, infraspinatus, flexor digitorum superficialis, abductor brevis pollicis, and first dorsal interosseous muscles were spared. MRI of the left brachial plexus and a contrast-enhanced bilateral breast MRI were performed to assess the supra-and infraclavicular fossa, to verify the left brachial plexus, and to exclude a recurrence of breast disease. The former immediately showed an extensive involvement of the supra-and infraclavicular soft a axilla, ABP abductor brevis pollicis, ADM abductor digiti minimi, ae above elbow, Amp amplitude, be below elbow, CV conduction velocity, DML distal motor latency, e elbow, EMG electromyography, Erb Erb's point, F minimal F-wave latency, L left, NCS nerve conduction study, R right, u unexcitable, w wrist Fig. 1 a-d Post-contrast T1-weighted MR coronal images, spoiled gradient recalled sequence (a, c), and high-definition fat-suppressed sequence (b, d), depict supra-and infraclavicular fossa and breast cancer metastasis, spreading (black arrow) from the subcutaneous layer to the subclavian artery in different slices. The two high-resolution sequences were allowed to understand the relationships between vascular structures and with neuronal ones respectively with the different image resolution. In a and c, greater vessels of mediastinum are well depicted; in c and d, breast cancer metastasis margins are better showed underling the surrounded structures infiltration. e-f US images at different slides of supra-and infraclavicular fossa of the left side, respectively in e and f, showing breast cancer metastasis involvements (black arrows) from the inter-scalene space to the pectoral minor muscle with neural cords displacement and infiltration (white arrows) tissues, from the subcutaneous layer to the left subclavian artery (Fig. 1a-d) , with an extension of about 45 × 37 × 48 mm; the latter showed two unknown mammary lesions of about 19 and 11 mm respectively, with irregular margins, at the lower external quadrant of the right breast. Targeted US examination of the supra-and infraclavicular fossa confirmed the extensive infiltration of the brachial plexus strings in several points with the cords displacement emerging from the inter-scalene space to the pectoralis minor muscle (Fig. 1e-f) . The patient was treated with chemotherapy (taxole and trastuzumab), and a complete disease remission was obtained as showed by imaging studies. After 6 months, clinical evaluation revealed mild improvement of strength in the affected muscles.
When approaching a patient with a nontraumatic brachial plexopathy associated with a previous diagnosis of breast cancer, the possibility of a loco-regional relapse should always be investigated. MRI and electrophysiological studies are the techniques of choice for evaluating patients with a nontraumatic brachial plexopathy [1] ; furthermore, imaging is crucial to distinguish benign from malign causes [3] . In our patient, clinical presentation with significant muscular weakness and atrophy of the deltoid muscle, which was markedly predominant compared to the involvement of biceps, triceps, and extensors of forearm and fingers, was insidious and initially could have raised the suspicion of an axillary neuropathy. Moreover, in our case, the patient had no pain, a characteristic that is more typical of radiation-or chemother apy-induced brachial plexopathy [4 ] . Electrophysiological evaluation was crucial to diagnose a brachial plexopathy and lead to perform imaging investigations. The latter promptly revealed breast cancer recurrence so that treatment was immediately started being well-tolerated and leading to disease remission. On the other hand, a delay in diagnosis and treatment would have caused an irrecoverable damage of the brachial plexus due to tumor infiltration and probably a further dissemination of cancer, thus worsening the prognosis.
